Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment.

Chen-Hua Liu Cheng-Yuan PengWei-Yu KaoSheng-Shun YangYu-Lueng ShihChin-Lin LinMeng-Kun TsaiChih-Yuan LeeChun-Chao ChangJo-Hsuan WuChun-Jen LiuTung-Hung SuTai-Chung TsengPei-Jer ChenJia-Horng Kao

Published in: Alimentary pharmacology & therapeutics (2021)

The risk of HCV reinfection in patients on haemodialysis who achieve SVR12 is low and comparable to that in the low-risk general population. HCV microelimination in this special population is feasible once universal screening and scaled-up treatment are implemented.

Keyphrases

hepatitis c virus
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
human immunodeficiency virus
prognostic factors
patient reported outcomes
antiretroviral therapy
replacement therapy
smoking cessation